Fuso Pharmaceutical Industries,Ltd. (TSE: 4538)
Health Care · Pharmaceuticals · JP
¥2,288.00
-1.17% today · +3.1% 1Y
Fuso Pharmaceutical Industries,Ltd. (TSE: 4538) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $122.62M and employs 1,370 people.
Over the last twelve months the share price has gained 3.1%, trading between 1.99K and 2.53K.
Tweenvest scores Fuso Pharmaceutical Industries,Ltd. across four factors: quality 67/100, value 42/100, growth 65/100, dividend 95/100. Its strongest factor is dividend.
4538 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $122.62M
- Revenue (TTM)
- $386.66M
- P/E
- 8.92
- EPS
- 256.62
- Dividend yield
- 3.89%
- Beta (5Y)
- 0.15
- 52-week high
- ¥2,530.00
- 52-week low
- ¥1,990.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.54M
- Employees
- 1,370
- Next earnings
- —
About Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. is a Japanese firm primarily involved in the development and commercialization of pharmaceutical goods. Their product range encompasses prescription medications, particularly injectables and solutions for artificial kidney dialysis, as well as various medical instruments and apparatus. Additionally, the company participates in real estate leasing. Established in 1937, Fuso Pharmaceutical's corporate headquarters are situated in Osaka, Japan.
- ISIN
- JP3823600006
- Founded
- 1937
- Listed since
- Jan 1, 2001
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,236.80 | +0.25% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.47 | +0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.38 | -0.04% |
| Roche Holding AGSWX: ROP | $371.62B | CHF374.20 | +0.11% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.68 | -0.87% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.